Announcements

Most recent Article
Final Results
Sativa Investments Plc (NEX: SATI), (or “Sativa” or “the Company” or “the Group”), the UK’s first quoted medicinal cannabis investment vehicle, is pleased to announce its Final Results from the date of incorporation to 31 December 2018.

Latest articles

Final Results

Sativa Investments Plc (NEX: SATI), (or “Sativa” or “the Company” or “the Group”), the UK’s first quoted medicinal cannabis investment vehicle, is pleased to announce its Final Results from the date of incorporation to 31 December 2018.

Exercise of Share Options and Total Voting Rights

Sativa Investments PLC (NEX: SATI), announces that it has allotted 6,666,667 new ordinary shares of 0.25 pence each in the Company (“Ordinary Shares”) pursuant to the exercise of share options. Application has been made for the new Ordinary Shares to be admitted to trading on the NEX Exchange Growth Market (“Admission”) and Admission is expected to become effective on 13th May 2019.

Sativa Strategic Update – 8th May 2019

Sativa Investments PLC (NEX: SATI), which joined the NEX Exchange Growth Market in March 2018 as the UK’s first medicinal cannabis investment vehicle, is pleased to announce a strategic update ahead of the Company’s announcement of audited results for the year ended 31 December 2018, scheduled for 13 May 2019.

Sativa to open first Goodbody & Blunt wellness centre in Bath with lease signed

Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, is to open the first of its Goodbody & Blunt wellness centres in Bath and has leased a 60.67 sq. m (653 sq. ft) retail unit with frontage on to the prime, high footfall, Broad Street and Milson Place City-centre shopping destinations.

Sativa begins cannabinoid research with King’s College London

Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle,has entered into a research agreement with King’s College London (“the College”) to research the impact of cannabinoids on inflammation and respiratory diseases.

Appointment of Director of Regulatory affairs

Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle,has appointed, with immediate effect, Dr Nick Horniman, BVSc MRCVS, as its Director of Regulatory Affairs, a senior management role, tocoordinate the Company’s overall regulatory strategy and ongoing relationships with regulators. 

Dr Brown appointed to Advisory Board

Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle,has appointed Dr Matthew Brown to its Medicinal Cannabis Advisory Board with immediate effect.

Sativa Investments PLC investment George Botanicals launches cannabidiol (CBD) balm and flavoured MCT oils (28th November 2018)

Sativa Investments PLC’s investee business, UK CBD manufacturer and distributor George Botanicals, has expanded its range of CBD products with the launch of a CBD balm, along with a range of MCT (medium-chain triglycerides) oils in raspberry, chocolate & hazelnut, and black-forest gateau flavours which complement drinks including coffee, tea and soft drinks.